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Abstract: Robust and balanced gut microbiota are required to support health and growth. Overgrowth
of gut microbial or pathogens can change ecosystem balance, and compromise gut integrity to initiate
gastrointestinal (GI) complications. There is no safe and effective modality against coccidiosis.
Antibiotic additives routinely fed to food animals to protect against infection, are entered into the
food chain, contaminate food products and pass to the consumers. Hypothesis: induced aberrant
organisms possess distinct ultrastructure and are tolerated by immunodeficient-animals yet are
non-pathogenic, but immunogenic in various strains of chicks to act as a preventive (vaccine)
and eliminating the needs for antibiotic additives. Methods: cyclophosphamide-immunodeficient
and immune-intact-chicks were inoculated with induced aberrant or normal Coccidal-organisms.
Immune-intact-chicks were immunized with escalating-doses of organisms. Results: Aberrant
organisms showed distinct ultrastructure with 8-free-sporozoites which lacked sporocysts walls and
veils. Immunodeficient-chicks inoculated with normal-organisms developed severe GI complications
but tolerated aberrant-organisms (p < 0.001) while they had no detectable antibodies. Naïve-animals
challenged with a pathogenic-dose showed GI complications, bloody diarrhea, severe lesions and
weight loss. Immune-intact-animals immunized with aberrant forms were protected against high dose
normal-pathogenic-challenge infection and gained more weight compared to those immunized with
normal-organisms (p < 0.05). Conclusions: Aberrant organisms possess a distinct ultrastructure and
are tolerated in immunodeficient-chicks, yet provide novel immune-protection against pathogenic
challenges including diarrhea, malnutrition and weight loss in immune-intact-animals to warrant
further investigations toward vaccine production.
Keywords: infection; gut inflammation; immunosuppression; poultry; coccidiosis; aberrant organisms
1. Introduction
Robust and balanced gut microbiota are required to support health and growth. Application of
certain medications and chemicals including antibiotics and immunmodulators can alter this delicate
balance in digestive tracts and promote the state of disease [1]. Antibiotics are designed and required
modality to abolish infectious pathogenic elements and to cure patients. Yet, antibiotics underlay a
dual conundrum, as they can destroy the normal gut microbiome and promote growth of pathogenic
organisms to cause dysbiosis. Further, altered permeability damages the gut mucosa and prone
individuals to diarrhea and gastroenteritis.
Cyclophoshamide (CY) is an alkylating agent and a potent immunosuppressant compound used
in humans against autoimmune diseases and cancer chemotherapy. CY affects both T and B cells;
however, B cells have a slower rate of recovery [2,3]. CY is metabolized in hepatic cells to yield active
substances and to exert cytotoxic effects on certain immune cells [4]. The cytotoxic effect is due to drug
cross-link DNA, which can immediately destroy affected cells, render them susceptible to cell death
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during mitosis, or permit normal cellular activities if DNA repair occur. Indeed, CY-chemotherapy
disrupts the gut epithelial barrier, and causes the gut to bypass certain bacteria. Bacteria gather in
lymphoid tissue just outside the gut and spur generation of T helper 1 and T helper 17 cells that
migrate to the tumor vicinity and destroy tumor cells [5]. In birds, immunoglobulin synthesis and
antibody production depend upon the integrity of bursa of fabricius lymphoid organ which is located
on the dorsal side of rectal “cloaca”. CY-treatment on the first three days after birth is reported to
severely depress antibody production as animals fail to produce antibodies against antigenic challenges
up to 7–11 weeks, similar to combined bursectomized and in ova X-irradiation [6]. In addition, CY
causes significant decreases in lymphoid population in thymus [2]. The splenic structure and preferral
lymphoid organs lost germinal and plasma cells. The variation in the action and the outcome reported
in different studies are due to the doses, the length and the time for initiation of CY-administration.
Coccidia are highly host specific transmissible Apicomplexan organisms which mainly attack
gut mucosa and compromise the immune system to trigger gastrointestinal inflammation, infectious
diarrhea, loss of function and morbidity in humans and animals. In contrast, Toxoplasma, another
member of the family Apicomplexan, is a ubiquitous organism which infects every organ and
cell in animals and humans to cause toxoplasmosis [7]. Coccidiosis is one of the most important
communicable pathogenic diseases in the food animals industry. Additionally, Coccidia predispose
infected animals to other pathogens like Clostridia and more severe necrotic enteritis [8]. There is no
safe and effective therapeutic modality or vaccine to protect against the infection [9].
Antibiotic additives are routinely fed to poultry and livestock as a common practice to protect
against the infection and weight loss. These additives contaminate egg, meat, bone and milk products
which are transferred into the food chain and consumed with predicted complications. For instance,
quinolones are commonly prescribed in patients while used in diets for the poultry industry to
increase weight gain and growth [10,11]. Quinolone residues are detected in 50% of eggs at higher
concentrations above the limits for edible tissues established by the regulatory agencies, including
United States Department of Agriculture [11]. Animal products contaminated with antibiotic residues
create a great concern about possible side effects in consumers such as allergies [12] and potential for
antibiotic-resistant microbials.
Coccidiosis causes great economic loss and morbidity by reduction in food intake, weight gain and
egg production, and also affects the value of meat quality by decreasing feed conversion, maldigestion
and malabsorption to lead in mortality [3]. The annual cost of coccidiosis in poultry production has
been estimated at $800 million in the USA [13,14], chiefly for anticoccidial drugs which are commonly
used to control the infection and to improve weight gain. The constant addition of medications in
food animal diets has been a profitable and effective tool against the disease outbreak, but there are
drawbacks including development of drug resistance and potential health side effects in consumers.
The live vaccine, Coccivac, is a mixture of seven species of poultry Coccidia which has been utilized
for over five decades in the USA [15]. The animals recover the infection from vaccines and develop
immunity which lasts days to weeks. The disadvantages of this vaccine include: poor feed conversion
to weight gain; several weeks are required to develop a solid immunity; possibility of spreading
infection; difficulties in administering the vaccine and managing the animals. Other possible vaccines
in experimental stages are attenuated strains including serially transferred Eimeria tenella (E. tenella)
into chorio-allantoic chick embryos [16].
Ever since its discovery (Fantham and Porter 1900), Eimeria [17] have been described as organisms
(oocysts) with four sporocysts, each containing two sporozoites. By utilizing purification procedures,
aberrant forms of different Eimerias were induced which matured to contain 8-free-sporozoites with no
protective sporocyst walls, as were confirmed by light microscopy [18]. The aberrant organisms proved
to be less pathogenic than the normal form in inbred Leghorn-chicks, but similarly immunogenic. The
hypothesis of this investigation was: induced aberrant organisms possess a distinct ultrastructure
and are tolerated by immunodeficient-animals, yet are non-pathogenic but immunogenic in various
strains of chicks to act as preventive (vaccine) and eliminating the need for antibiotic additives. This
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investigation reports the ultrastructural formation of these novel organisms and further compares
their pathogenecity to normal forms in immunodeficient and susceptible animals. In addition,
immunogenicity of these aberrant forms is examined and compared to normal organisms utilizing two
diverse inbred chicks, Rhode Island Red and New Hampshire strains.
2. Materials and Methods
2.1. Ethical Guidelines for the Use of Animals
This investigation was conducted according to the guidelines of the National Institute of Health
and the International and the American Pain Associations. All animal procedures were approved by
the University of Kentucky Institutional Animal Care and Use Committee (IACUC) and Institutional
Biosafety Committee.
2.2. Animals
One-day-old (neonate) specific pathogen-free inbred Rhode Island Red and inbred New
Hampshire chicks were obtained from the Poultry Science, and kept in Coccidia and pathogen-free
rooms, in disinfected wire-floor cages and provided feed and water ad libitum. Each bird was tagged
with a leg band and weighed prior, during and at the end of each study. Weight gain/loss was
calculated by subtracting the initial weight before inoculation from the weight obtained following
challenge and before termination.
Cyclophosphamide Immunosuppressed Birds
Immunodeficient birds were utilized in order to investigate fine pathological differences between
the normal or aberrant organisms. Neonate (1-day-old) Rhode Island Red chicks were intramuscularly
(IM) administered with 4 mg (100 mg/kg) cyclophosphamide (CY, Sigma Chemical Co., St. Louis, MO,
USA) for 4 consecutive days, in order to suppress B and T cells and immune responses [3]. T cells may
partially recover after one month; however, B cells’ suppression can last for several months.
2.3. Preparation of Organisms (Oocysts)
Mature organisms (sporulated oocysts) of E. tenella originally were obtained from Eli Lilly and Co.
(Indianapolis, IN, USA). Fresh cultures were prepared from the ceca of donor birds one week after oral
inoculation. The contents were homogenized and the immature organisms were separated from debris
by sieve and centrifuged at 400× g and sediments added into 2.5% aqueous potassium dichromate to
obtain mature normal organisms. In order to induce aberrant organisms, the homogenate containing
immature (unsporulated) organisms were cleaned in a solution of 2.5% sodium hypochlorite, and
rinsed with distilled water (2×). The homogenates were centrifuged for 10 min at 400× g in a saturated
salt solution (9:1:v.v), then rinsed in distilled water and cultured in 2.5% aqueous potassium dichromate
solution to enhance maturation. Organisms were declared mature when at least 90% had reached
maturation (sporulated). The organisms were enumerated using a hemocytometer and diluted into
PBS according to the required numbers per each experiment before organisms gavaged directly into
crop. Normal control animals received sham (PBS) treatment by gavage.
At 2–6 weeks of age, animals were gavage inoculated via crop respectively with any dose of
240, 300, 450, 2400, or 24,000 mature organisms of either normal or aberrant strains (Scheme 1). Each
experimental animal received one dose at a time and up to three doses with 2 weeks interval according
the experimental design. Infected animals (New Hampshire, Rhode Island Red) were kept in isolation
wired cages into separate rooms and provided with food and water ad lib. Cages were daily cleaned
and disinfected.
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Scheme 1. Schematic timeline immunization for 2 strains of chicks (New Hampshire and Rod Island 
Red) with aberrant (Aber) or normal (Nor) organisms and challenge with highly pathogenic dose 
(24,000) of normal organisms. 
2.4. Blood and Tissue Collection 
One week after the last challenge dose of inoculum, animals were weighed, and blood was 
collected into syringes from the wing basilic vein using 25 gauge needles. Animals were humanely 
euthanatized by cervical dislocation immediately followed by cardiac puncture and tissues 
collected. Blood was centrifuged and serum aliquots were stored at −20 °C until used. Intestines 
were immediately removed and examined and a portion of cecal tissues fixed in buffer formalin 
solution. Slide smears were prepared from the rest of cecal tissues to detect the organisms. 
Histopathological Scoring 
Histopathological slides were prepared from 6 animals/each group and sections stained with 
Hematoxylin and Eosin. Slides were numerical-labeled (coded) at the pathology lab during the 
automated staining process. Every field on each pathological slide was thoroughly examined for 
changes and possible damage. Cecal lesions were scored from 0 to 5 according to the severity of 
infection [3,18]. 
0 = Normal mucosa, and negative cecal smears. 
1 = No detectable pathology but organisms detected in the smears. 
2 = Scattered petechia on mucosa, organisms present on the smear, normal cecal contents. 
3 = Focal inflamed and thickened mucosa, some hemorrhage in lumen. 
4 = Multifocal inflammation and thickened mucosa, extensive hemorrhage in the lumen, with 
little or no fecal contents, weight loss. 
5 = Severe inflammation and necrosis, enlarged ceca with blood or sloughed off mucosa, 
moribund or dead birds. 
Slides were decoded after completion of pathological evaluation. 
2.5. Maturation of Organisms (Oocysts Sporulation) 
Maturation was determined via microscopic examination. Representative samples were 
examined and percentage of sporulated organisms determined every 4 h. Maturation was achieved 
when 90% or more of organisms had completed developmental stages. 
Scheme 1. Schematic timeline immunization for 2 strains of chicks (New Hampshire and Rod Island
Red) with aberrant (Aber) or normal (Nor) organisms and challenge with highly pathogenic dose
(24,000) of normal organisms.
2.4. Blood and Tissue Collection
One week after the last challenge dose of inoculum, animals were weighed, and blood was
collected into syringes from the wing basilic vein using 25 gauge needles. Animals were humanely
euthanatized by cervical dislocation immediately followed by cardiac puncture and tissues collected.
Blood was centrifuged and serum aliquots were stored at −20 ◦C until used. Intestines were
immediately removed and examined and a portion of cecal tissues fixed in buffer formalin solution.
Slide smears were prepared from the rest of cecal tissues to detect the organisms.
Histopathological Scoring
Histopathological slides were prepared from 6 animals/each group and sections stained with
Hematoxylin and Eosin. Slides were numerical-labeled (coded) at the pathology lab during the
automated staining process. Every field on each pathological slide was thoroughly examined for
changes and possible damage. Cecal lesions were scored from 0 to 5 according to the severity of
infection [3,18].
0 = Normal mucosa, and negative cecal smears.
1 = No detectable pathology but organisms detected in the smears.
2 = Scattered petechia on mucosa, organisms present on the smear, normal cecal contents.
3 = Focal inflamed and thickened mucosa, some hemorrhage in lumen.
4 = Multifocal inflammation and thickened mucosa, extensive hemorrhage in the lumen, with
little or no fecal contents, weight loss.
5 = Severe inflammation and necrosis, enlarged ceca with blood or sloughed off mucosa, moribund
or dead birds.
Slides were decoded after completion of pathological evaluation.
2.5. Maturation of Organisms (O cysts Sporulation)
Maturation was determined via microscopic examination. Representative samples were examined
and percentage of sporulated organisms determined every 4 h. Maturation was achieved when 90% or
more of organisms had completed developmental stages.
2.6. Enzyme Linked Immosorbent Assay (ELISA)
The indirect ELISA technique was performed using a soluble oocyst antigen of E. tenella according
to [3,18,19]. Each serum sample was heat inactivated at 56 ◦C for 30 min before use and diluted in
two-fold increments. Peroxides conjugated
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Chester, PA, USA) was dispensed into each micro-well coated with 11 µg of antigen, and incubated
with o-phenylenediamine (Eastman Kodak Co., Rochester, NY, USA). Optical densities were read at
490 nm on ELISA reader (DYnatech Lab Inc., Alexandria, VA, USA).
2.7. Experimental Design
In the first experiment, 2-weeks-old and 3-weeks-old inbred CY-immunodeficient-animals were
inoculated with 300 and 450 organisms, respectively, of either normal or aberrant form. To compare
the immunogenic efficacy, 3-weeks-old inbred New Hampshire or Rhode Island Red animals received
240 and 2400 oocysts of normal or aberrant organisms at a two-week interval. Then, animals
were challenged with a high pathogenic dose (24,000) of normal organisms. One week after each
inoculation, six animals from each group were weighed and bled, then euthanized to collect samples
for pathological investigations.
2.8. Frozen Sections
Organisms were centrifuged in 20% (w/v) bovine serum albumin (BSA) and 15% (w/v) sucrose.
The pellets were fixed with 2 drops/mL of 25% glutaraldehyde. Sections were quick frozen in liquid
nitrogen and blocks were sectioned at the 18 µm setting on cryostat. Organisms were embedded with
mounting agent to protect from shattering during the sectioning procedure. The sections were stained
with Hematoxylin and Eosin.
2.9. Electron Micrographs
The ultrastructural modifications of aberrant and normal organisms were investigated during
maturation. Therefore, organisms were embedded in cross-linked BSA media and frozen in liquid
nitrogen prior to cryostat sectioning at 16 µm. These sections were directly immersed in Carnovsky
fixative, re-embedded in BSA, post fixed in osmium tetroxide and embedded in osmium tetroxide and
finally embedded in Spurr’s Plastic. The blocks were sectioned with KLB ultramicrotome 111 with
a diamond knife. The sections were stained with uranyl acetate and lead citrate and examined with
Ziess EM Transmission Electron Microscope (TEM) and micrographs were developed.
2.10. Statistical Analysis
Parameters were analyzed with Prism 6 software (Graph Pad Software, Inc., La Jolla, CA, USA).
Data are expressed as mean ± SEM unless otherwise stated. One hundred organisms were monitored
each time from 3 different samples. Maturation of organisms was calculated when a minimum of 90%
of organisms formed infective sporozoites. Weight gain/loss was calculated by subtracting the initial
weight before inoculation from the weight obtained following each challenge inoculation and before
termination. Statistical analysis was performed utilizing a two-way analysis of variance (ANOVA)
followed by Bonferroni multiple comparison post hoc test for comparisons. Statistical significance was
set at p ≤ 0.05.
3. Results
3.1. Maturation and Ultrastructure
Ultrastructural modifications during developmental maturation were investigated to compare
aberrant and normal organisms utilizing transmission electron micrographs. Normal organism
development was completed after 34 h of maturation (sporulation) when they contained 4 fully
formed sporocysts each to shield 2 infective sporozoites within. Sporocysts walls and sporocysts
veil ultrastructures visible by TEM (Figure 1A,B) were required to sustain their infectivity, as will be
presented. In contrast, aberrant organism maturation was more sluggish and about 23% longer than
normal organisms (44 h vs. 34 h).
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honey-combed chamber, nucleolus (Nu) ×7000. (B) A normal organism under light microscopy 
with 3 of 4 sporocysts ×800. (C) Enlarged micrograph from mature sporocyst contains 2 mature 
sporozoites within the sporocyst’s wall 34 h of developmental stage. Each sporozoite contains 
refractile bodies ×13,000. Note Nucleus (N), Dense body (DB), Anterior (AR) and posterior refractile 
bodies (PR), Rhoptry (Rh), nucleolus (Nu), Sprocyst veil (SW), Oocyst wall (OW).  
Aberrant organisms had free naïve sporozoites within the oocysts confinement without any 
protective sporocysts walls and veils (Figure 2A–C) dissimilar to normal ones. Further, aberrant 
organisms had fragile outer membranes (oocyst wall) which disrupted in occasions during TEM 
process for ultrastructure investigation. In addition, aberrant organisms contained 2 masses of 
rudimentary organelles as residuum of sporocysts (Figure 1C). However, normal and aberrant 
organisms both had an equal number of (8) banana-shape-sporozoites. Aberrant sporozoites 
similarly contained nucleus, rhoptries, conoidal piercing organelles, and polar rings and fibrillate 
ultrastructures required for invasion and lodging into gut epithelial cells. Otherwise, aberrant 
organisms appeared to have similar microstructures to normal ones in shape (round to oval), 
measurements (25 to 35 µm by 22.5 to 27.5 µm) and the size of each banana-shaped free sporozoite 
(12.5–14 µm by 2.5 µm). Over 90% of immature organisms processed to mature into the aberrant 
form, compared to 95% of normal organisms. This study proved the specific protective effects of the 
sporocysts provided for the longevity and infectivity of the sporozoites. 
Figure 1. (A,C) Transmission electron micrographs (TEM) from mature (A,C) and light micrograph
(B) from normal organism representative (E. tenella). (A) Mature normal organism (oocyst)
representative 34 h of developmental stage (sporulation) demonstrating 3 of 4 sporocysts, oocyst
wall (OW), Stieda body (SB), sporocysts wall (SW), sporocysts veil (SV) dividing the organism into a
honey-combed chamber, nucleolus (Nu) ×7000. (B) A normal organism under light microscopy with
3 of 4 sporocysts ×800. (C) Enlarged micrograph from mature sporocyst contains 2 mature sporozoites
within the sporocyst’s wall 34 h of developmental stage. Each sporozoite contains refractile bodies
×13,000. Note Nucleus (N), Dense body (DB), Anterior (AR) and posterior refractile bodies (PR),
Rhoptry (Rh), nucleolus (Nu), Sprocyst veil (SW), Oocyst wall (OW).
Aberrant organisms had free naïve sporozoites within the oocysts confinement without any
protective sporocysts walls and veils (Figure 2A–C) dissimilar to normal ones. Further, aberrant
organisms had fragile outer membranes (oocyst wall) which disrupted in occasions during TEM process
for ultrastructure investigation. In addition, aberrant organisms contained 2 masses of rudimentary
organelles as residuum of sporocysts (Figure 1C). However, normal and aberrant organisms both had
an equal number of (8) banana-shape-sporozoites. Aberrant sporozoites similarly contained nucleus,
rhoptries, conoidal piercing organelles, and polar rings and fibrillate ultrastructures required for
invasion and lodging into gut epithelial cells. Otherwise, aberrant organisms appeared to have similar
microstructures to normal ones in shape (round to oval), measurements (25 to 35 µm by 22.5 to 27.5 µm)
and the size of each banana-shaped free sporozoite (12.5–14 µm by 2.5 µm). Over 90% of immature
organisms processed to mature into the aberrant form, compared to 95% of normal organisms. This
study proved the specific protective effects of the sporocysts provided for the longevity and infectivity
of the sporozoites.
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preconoidal rings (R), polar ring (Pr), and microneme (Mi). ×11,600. (C) Cryostat section stained 
with Hematoxylin and Eosin of mature aberrant organism demonstrates 8 free sporozoites, polar 
granule and 2 masses of oocyst residuum and lack of sporocyst structure. Light microscopy ×790. 
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aberrant and normal organisms. Neonate chicks were exposed to cyclophosphamide treatment for 4 
consecutive days, compared to the sham-treatment in immune-intact animals. 
CY-treated-immunodeficient animals had extensive stunt development as appeared with bare skin 
and patchy feather growth. Respectively, at 2 or 3 weeks-old, CY-immunodeficient-juvenile chicks 
were gavage inoculated with low doses of mature (2 weeks with 300 or 3 weeks with 450) normal 
or aberrant organisms. Animals treated with normal organisms became moribund and developed 
severe GI inflammatory responses and bloody diarrhea, and gained significantly less weight (Figure 
3, Table 1). In contrast, CY-immunodeficient-animals tolerated aberrant organisms with 
significantly more weight gain and pathological lesions (p < 0.001). As was expected, 
CY-immunodeficient animals developed no detectable (protective) antibodies in contrast to 
immune-intact animals. In gross pathology, CY-immunodeficient animals had rudimentary 
thymus, splenic and bursa of Fabricius structures (data not shown) due to the cytotoxic effect of CY 
on B and T cell formation. Yet, immunodeficient animals treated with normal organisms presented 
significantly severe pathological damages to the gut than those treated with aberrant forms. These 
data support that aberrant organisms are significantly less invasive and less pathogenic than normal 
forms (Figure 3, Table 1). All normal animals were protected against challenge doses with no visible 
intestinal lesions or organisms detected from their intestinal smears. In contrast, all 
CY-immunodeficient animals were unprotected against low doses of challenge infection (data not 
shown). 
Figure 2. (A–C) Mature aberrant organism. (A) Transmission electron micrograph (TEM) from mature
aberrant organism representative contains free sporozoites. Micrograph demonstrates section through a
mature aberrant organism 44 h after development. Unlike normal, aberrant organisms lack sporocysts,
sporocysts wall and veil and stieda body as evidenced. ×7000. (B) High magnification of the anterior
end from free sporozoite showing conoid (Co), piercing organelles, preconoidal rings (R), polar ring
(Pr), and microneme (Mi). ×11,600. (C) Cryostat section stained with Hematoxylin and Eosin of mature
aberrant organism demonstrates 8 free sporozoites, polar granule and 2 masses of oocyst residuum
and lack of sporocyst structure. Light microscopy ×790.
3.2. Immunodeficiency and Comparative Pathogenicity
An induced immunodeficient model was utilized to compare the fine detailed pathogenecity
of aberrant and normal organisms. Neonate chicks were exposed to cyclophosphamide
treatment for 4 consecutive days, compared to the sham-treatment in immune-intact animals.
CY-treated-immunodeficient animals had extensive stunt development as appeared with bare skin and
patchy feather growth. Respectively, at 2 or 3 weeks-old, CY-immunodeficient-juvenile chicks were
gavage inoculated with low doses of mature (2 weeks with 300 or 3 weeks with 450) normal or aberrant
organisms. Animals treated with normal organisms became moribund and developed severe GI
inflammatory responses and bloody diarrhea, and gained significantly less weight (Figure 3, Table 1).
In contrast, CY-immunodeficient-animals tolerated aberrant organisms with significantly more weight
gain and pathological lesions (p < 0.001). As was expected, CY-immunodeficient animals developed
no detectable (protective) antibodies in contrast to immune-intact animals. In gross pathology,
CY-immunodeficient animals had rudimentary thymus, splenic and bursa of Fabricius structures
(data not shown) due to the cytotoxic effect of CY on B and T cell formation. Yet, immunodeficient
animals treated with normal organisms presented significantly severe pathological damages to the gut
than those treated with aberrant forms. These data support that aberrant organisms are significantly
less invasive and less pathogenic than normal forms (Figure 3, Table 1). All normal animals were
protected against challenge doses with no visible intestinal lesions or organisms detected from their
intestinal smears. In contrast, all CY-immunodeficient animals were unprotected against low doses of
challenge infection (data not shown).
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Table 1. Effects of low doses of aberrant and normal organisms in juvenile immunodeficient or
immune-intact Rhode Island Red animals.
Gp Week Old CY Treated Organism/ Weight Gain Ab Titer
1 2 + 300 N 60 ± 3.4 0
2 2 + 300 A 57 ± 5.7 0
3 3 + 450 N 87 ± 7.2 b 0
4 3 + 450 A 106 ± 7 0
5 3 −N * 450 N 95 ± 1.4 50 ± 1
6 3 −N * 0 190 ± 8 0
Cyclophosphamide (CY) immunodeficient (+) or immune-intact (−) chicks were inoculated with a low dose of
300 (2 weeks old) or 450 (3 weeks old) normal or aberrant organisms. Two weeks and three weeks old (CY)
immunodeficient animals were chosen when lacking both T and B cells. Data is shown as mean ± SEM. Gp = Group,
N = Normal organisms, A = Aberrant organism, N * = Normal Immune-intact birds. Mean Body Weight gain/g.
N = 6/group. b p < 0.05.
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Figure 3. Pathological scores from Cylophosphamide (CY)-immunodeficient animals inoculated with
300 (at 2 weeks of age) or 450 (at 3 weeks of age) of either mature (sporulated) aberrant or normal
organisms. Samples are collected 1 week after initiation of infection by oral gavage. Statistically
significant pathological damages were detected in animals treated with normal organisms compared
to aberrant forms (p < 0.01). As expected no antibody production was detected in sera from these
CY-immunodeficient animals.
3.3. Organisms and Protective Immunogenicity
There is a strain variation in immune response against organisms amongst chicks. Therefore,
2 different inbred strains, Rhode Island Red and New Hampshire immune-intact animals were utilized
for this experiment in order to compare protective immune response against infection. Further, day-old
chicks lack immunity but consume their egg yolk which is rich in maternal immunity and become
protected against pathogens during the first week of their life. However, in the second week as
maternal immunity weans off, chicks become sensitive to infections and start to develop their active
immunity. Therefore, two-weeks-old chicks were used to initiate the following investigations as these
animals are sensitive to infections yet capable of launching an immune response against pathogens.
Two-weeks-old animals were immunized with serial inoculations of aberrant or normal forms (240 and
2400) with 2 weeks interval. All animals were challenged with a high pathogenic dose of normal form
(24,000). Those animals immunized with aberrant organisms gained weight more and developed lower
cecal pathological lesions than those immunized with normal organisms. These animals were protected
against the challenge infection (Tables 2–4). Naïve unimmunized animals challenged with a pathogenic
dose (24,000 normal organisms) lost weight and developed severe bloody diarrhea and significantly
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more extensive inflammatory pathological lesions than immunized animals (unimmunized 3.2–4.1 vs.
immunized 0–1) (Table 4).
Table 2. Immune-intact animals were immunized with first dose of normal or aberrant organisms at
week 1.
Gp Birds Strain Strain Organism/ Weight Gain Lesion Ab Titer
1 New Hampshire A 240 104 ± 5 1 ± 0.1 b 0
2 “ N 240 85 ± 7 1.3 ± 01 0
3 “ C 0 123 ± 7 * 0 0
4 Rhode Island Red A 240 114 ± 3 1 ± 0.1 0
5 “ N 240 95 ± 2 1 ± 0.1 0
6 “ C 0 190 ± 3 * 0 0
Six birds/group (Gp) were inoculated with Normal (N) or Aberrant (A) organisms (week 1). Data is shown as
mean ± SEM. Normal control (C) birds received (0) sham inoculation. Lesion scores. Mean Body Weight gain/g.
N = 6/group. b p < 0.05. * p < 0.01.
Table 3. Animals immunized with second dose of normal or aberrant organisms. Six/group animals
which were immunized with 240 and 2400 Normal (N) or Aberrant (A) organisms (week 4) with
2-weeks interval. Control (C) birds received (0) sham inoculation.
Gp Bird Strain Strain Organism/ Weight Gain Lesion Ab Titer
1 New Hampshire A 2400 133.4 ± 6 1 ± 0.1 58.0 ± 2 b
2 “ N 2400 133.4 ± 3 1 ± 0.1 50.0 ± 1
3 “ C 0 247.4 ± 2 0 0
4 Rhode Island Red A 2400 152.3 ± 1 * 1 ± 0.2 b 25.0 ± 2 *
5 “ N 2400 104.9 ± 2 1.4 ± 0.1 17.0 ± 1
6 “ C 0 218.9 ± 5 0 0
Data is shown as mean ± SEM. Lesion scores. Mean Body Weight gain/g. N = 6/group. b p < 0.05;* p < 0.01.
Table 4. Immunized animals with two different doses of normal or aberrant were challenged at 6 weeks
of age with high numbers of infective normal organisms.
GP Bird Strain Strain Organism/ Weight Gain Lesion Ab Titer
1 New Hampshire A 24,000 100 ± 2 * 0 b 69 ± 4 b
2 “ N 24,000 50 ± 3 0.35 ± 0.1 63 ± 2
3 “ N * 24,000 −45 ± 2 # 3.2 ± 0.5 50 ± 3
4 “ C 0 247 ± 5 0 0
5 Rhode Island Red A 24,000 72 ± 3 0.76 ± 0.1 b 44 ± 6 b
6 “ N 24,000 64 ± 3 1 ± 0.2 81 ± 2
7 “ N * 24,000 −80 + 4 # 4.1 ± 0.3 ND
8 “ C 0 219 ± 7 0 0
Six birds/group were immunized with 240 and 2400 Normal (N) or Aberrant (A) organisms (weeks 2 and 4) with
2-weeks interval. Control (C) animals received (0) sham inoculation. Infected control group (N *) received no
previous immunization before final challenged inoculum. Lesion scores. Mean Body Weight gain/g significant.
ND = Not done. b p < 0.05; * p < 0.01; # p < 0.001.
In general, Rhode Island Red animals were found to be more susceptible to disease, as they
developed more severe lesions and significantly less weight gain compared to New Hampshire
animals (Tables 1–3). In addition, naïve Rhode Island Red animals developed significantly more severe
pathological lesions (4.1 + 0.3 vs. 3.2 + 0.5 p < 0.05) and lost weight more (p < 0.01) than naïve New
Hampshire animals (Table 4).
Animals immunized with aberrant forms were protected against the challenge infection, gained
more weight, developed significantly less or no cecal lesions and more antibodies (except Rhode
Island Red), compared to those immunized with normal organisms (p < 0.05). Rhode Island Red
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animals immunized with aberrant organisms developed significantly less lesions compared to those
immunized with normal organisms, yet released significantly less Ab than those immunized with
normal strains. However, the reason behind this discrepancy is not known. Uninfected control animals
remained anti-coccidal antibody negative. There was a minor difference between the lesion scores
from immunized animals but it did not reach significance. These investigations proved that the
sporocysts are required to preserve infectivity in these organisms. Overall, aberrant organisms were
less pathogenic in immunodeficient animals yet protective in immunocompetent animals against the
challenge infection.
4. Discussion
Coccidiosis causes severe gut inflammation, diarrhea, malabsorption, malnutrition and weight
loss. The common preventive practice against coccidiosis in poultry and livestock includes application
of antibiotic supplementation into daily diets which contaminates eggs, milk, and meat production.
Antibiotics enter the food cycle and are consumed by humans with possible allergies, antibiotic
resistance, and other yet unknown side effects. Antibiotic additives include tetracyclines, as commonly
used in poultry, and are deposited and remain in bones and meat products. They become a potential
human health risk regardless of monitoring appropriate antibiotic withdrawal times before reaching
the market [20]. Further, sulfonamide use in the form of anticoccidial additives in food animals has
encountered the emergence of drug-resistant strain infections [21]. The Center for Disease Control and
Prevention (CDC) has speculated that annually over 2,000,000 sicknesses and 23,000 mortalities are due
to microbial resistance to antibiotics in the USA. Recent consumer awareness regarding the antibiotic
residue polluting food animal products and antibiotic resistant microbials has created trepidation
and specific recommendations to diminish overuse of antibiotics as growth promoters in livestock in
the USA [22] and worldwide. However, these recommendations may not be effective or applicable
without surrogate implementations such as safe and effective as well as feasible vaccine availability
against economically important coccidiosis in the food animal industry. The focus of this investigation
was on discovery and establishment of proof-of-concept in basic methodology, for development of
aberrant organisms to lead as candidate vaccines in coccidiosis.
Cyclophosphamide is a potent immune-modulating agent discovered in 1959 and ever since has
been used in autoimmune diseases and as a chemotherapeutic in cancer. CY is metabolized to active
form 4-hydroxy-CY, which spontaneously breaks down to reactive intermediates, phosphoramide
mustard and acrolein [23]. Phosphoramide mustard possesses an alkylating property which mediates
the anti-proliferative and cytotoxic actions of CY and cross links DNA with mitotic B and T cells.
In birds, immunoglobulin synthesis and antibody formation are regulated by Bursa of Fabricius,
and CY destroys bursal B cells as well as thymus T cell populations/production [2,3]. After four
consecutive days of treating neonate chicks with a cytotoxic agent, CY-treated juvenile animals visibly
lacked immune processing organs, thymus and bursa and bared rudimentary splenic structures.
CY-immunodeficient animals had pervasive growth stunting and weighed significantly less than
immune-intact animals (60%). Therefore, these animals were found to be more susceptible to
infections when challenged with a lower dose of organisms and developed more severe lesions
than immune-intact animals. Additionally, immunodeficient animals had no detectable antibody
titers in their sera even after being exposed with invasive organisms. Immunodeficient animals were
challenged with organisms at two or three weeks of age when they lack both active B-cells and T-cells;
while recovery of T-cells usually occurs after four weeks and B-cells after 7–12 weeks of age [2,3].
Further, coccidiosis is an immunosuppressive disease which weakens the immune system specifically
in juvenile animals. Intestinal pathological scores caused by normal organisms were significantly
more severe than those inoculated with aberrant organisms in both experiments. Yet, these animals
endured the aberrant organisms proving the concept that altered organisms were significantly of
low-pathogenicity even in immunodeficient animals. CY may cause GI effects; however, no attempts
were taken to eliminate CY possible side effects on GI tracts except practicing extreme hygiene in
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animals. It is plausible that some of the pathological findings in these immunodeficient animals could
have been provoked by CY more than direct effects from coccidial infection. Nevertheless, CY was
similarly used in all immunodeficient animals. Therefore, differences obtained between various groups
of immunodeficient animals can be mainly attributed to the pathogenic strength of normal versus
aberrant organisms than direct effects from CY on GI tracts.
Strains of chicks with phenotypic differences may express various immunological/pathologic
responses and resistance/susceptibility to diseases. In this investigation, two inbred strains, Rhode
Island Red and New Hampshire, were chosen in order to compare immune responses against
coccidial infection. Differences were detected in weight gain/loss. Naïve Rhode Island Red animals
developed more severe lesions compared with New Hampshire animals. New Hampshire animals
were significantly more robust and gained weight more and better tolerated challenge infections
compared to the Rhode Island Red animals. As expected, uninfected control animals remained
anti-coccidal antibody negative, while protective antibody titers were detected in immunized animals
with aberrant forms. Yet, both strains became effectively and better protected with aberrant forms
against ultimate infectious challenge than those immunized with normal forms. Aberrant organisms
provoke immunity without pathogenicity. The pathogenicity after challenge was significantly lower in
both groups of animals immunized with aberrant organisms. These included lack of bloody diarrhea
and severe weight loss. In addition, the level of Ab production was significantly higher in the New
Hampshire group immunized with aberrant, but not in Rhode Island Red animals. It is not clear
whether the discrepancy in Ab production is due to immune response differences in animal strains or
if other factors may have influenced the results. It is conceivable that higher titers of Ab production
may not be protective in some strains of animals as seen in severe cases of infections and autoimmune
diseases with unproductive surges of Ab production. These investigations proved that the sporocysts
are required to preserve infectivity of the organisms. Overall, both animal strains tolerated better
immunization with aberrant forms, gained more weight during immunization and when challenged
with high dose pathogenic form compared to those immunized with normal forms, as presented in the
results section.
This technique may be applicable to be used in other Apicomplexan organisms. For instance,
Toxoplasma is another related member of Apicomplexan organisms with severe acute and chronic
complications as well as feto-maternal syndrome in humans and animals. Toxoplasma has an intra
intestinal (coccidian forms) exclusive in cats as a definitive host and in extra intestinal stages is
cosmopolitan as it infects intermediate hosts (all animals and man), as well as every single organ and
cell in the body [7,24–26]. It is conceivable that the same modifications may be applicable for oocysts
of Toxoplasma to form aberrant organisms for a safe vaccine to immunize cats against toxoplasmosis as
a preventive measure to protect humans and animals against disease.
A century after the original discovery of poultry coccidiosis (Eimeria), a unique method of altering
infectivity of organisms has been achieved, as presented in this investigation. Previous studies had
either relied on genetic variation and selection in chicks [27], or altered organisms by exposing them
to irradiation [28]. The viable vaccination with Coccivac, which is a mixture of different pathogenic
Eimerias in chicks, has been used for over 60 years (Edgar 1952) in the USA [15] with several side
effects. The pathogenic live vaccine promotes weight loss and poor feed conversion and extends the
required time to develop solid protective immunity response to encounter the disease, the possibility
of leading to new infections and difficulties in preparation, administration and husbandry of the flocks.
Other experimental attempts for vaccine production include attenuated strains and serial passages
of E. tenella into chorio-allantoic chick embryo [16] which were proved to be ineffective. Our current
report is supported by previous findings related to altered organisms from two different pathogenic
strains, E. tenella and E. necatrix, using two different strains of inbred White Leghorn chicks [18]. In this
study, the inbred New Hampshire response was in accord with White Leghorns immunized with
aberrant organisms with complete protection from challenge infection and diarrhea. This study further
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exposed the ultrastructures of organisms and proved specific roles for sporocysts walls and veils to
sustain pathogenicity and longevity of the infective sporozoites.
5. Conclusions
Overall, aberrant organisms were significantly less pathogenic in immunodeficient animals
compared to the normal organisms, yet protective in immunocompetent animals against severe
challenges. As proof of concept, lack of protective ultrastructures (sporocysts walls and veils), reduced
pathogenicity, including diarrhea and weight loss, and preserved immunogenicity seems appropriate
to indicate a potential use for the aberrant organisms to warrant further trials for possible attenuated
vaccine production in future investigations.
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